FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: ERα+ Breast Cancer|ESR1 Gene Mutation
Interventions: DRUG: Tamoxifen|DIAGNOSTIC_TEST: FES PET/CT
Sponsor: University of Wisconsin, Madison